Skip to content

MATINAS BIOPHARMA HOLDINGS, INC.: 10-Q filed 2017-08-08

What MATINAS BIOPHARMA HOLDINGS, INC. reported in its quarterly report filed 2017-08-08 (fiscal Q2 2017): 28 published measures, 76 facts as tagged in accession 0001144204-17-040982.

This filing

Form
10-Q (quarterly report)
Filed
2017-08-08
Fiscal period
fiscal Q2 2017
Accession
0001144204-17-040982 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MATINAS BIOPHARMA HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-06-3017,799,913USD
At 2016-12-319,816,341USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-06-302,591,654USD
At 2016-12-312,666,380USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-06-3015,208,259USD
At 2016-12-317,149,961USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-06-3011,266,433USD
At 2016-12-314,105,451USD
At 2016-06-30578,313USD
At 2015-12-313,226,997USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-3,967,640USD91
2017-01-01 to 2017-06-30-8,463,757USD181
2016-04-01 to 2016-06-30-1,623,885USD91
2016-01-01 to 2016-06-30-3,868,495USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-06-30789,705USD181
2016-01-01 to 2016-06-300USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-04-01 to 2017-06-3044,906USD91
2017-01-01 to 2017-06-3059,875USD181
2016-04-01 to 2016-06-300USD91
2016-01-01 to 2016-06-300USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-06-3043,643,467USD
At 2016-12-3135,179,710USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-06-301,170,983USD
At 2016-12-31356,143USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-01-01 to 2017-06-301,687,690USD181
2016-01-01 to 2016-06-30793,471USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-3,976,303USD91
2017-01-01 to 2017-06-30-8,463,527USD181
2016-04-01 to 2016-06-30-1,620,229USD91
2016-01-01 to 2016-06-30-3,857,717USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-06-3011,739,064USD
At 2016-12-314,565,488USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-06-301,335,151USD
At 2016-12-311,444,793USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-06-30453,220USD
At 2016-12-31475,602USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2017-06-301,336,488USD
At 2016-12-311,336,488USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-04-01 to 2017-06-304,021,209USD91
2017-01-01 to 2017-06-308,523,402USD181
2016-04-01 to 2016-06-301,620,229USD91
2016-01-01 to 2016-06-303,857,717USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-04-01 to 2017-06-302,314,716USD91
2017-01-01 to 2017-06-304,698,934USD181
2016-04-01 to 2016-06-30642,576USD91
2016-01-01 to 2016-06-301,564,287USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-06-3091,972,323shares
At 2016-12-3158,159,495shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-06-3053,045,284USD
At 2016-12-3136,237,504USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2017-06-301,336,000USD
At 2016-12-31496,000USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2017-06-30165,000USD
At 2016-12-31140,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-06-30731,671USD
At 2016-12-31829,724USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-06-30317,254USD
At 2016-12-31304,427USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-04-01 to 2017-06-30-3,967,640USD91
2017-01-01 to 2017-06-30-25,205,113USD181
2016-04-01 to 2016-06-30-1,623,885USD91
2016-01-01 to 2016-06-30-3,868,495USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-301,706,493USD91
2017-01-01 to 2017-06-303,824,468USD181
2016-04-01 to 2016-06-30977,653USD91
2016-01-01 to 2016-06-302,293,430USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-04-01 to 2017-06-3012,000USD91
2017-01-01 to 2017-06-3024,800USD181
2016-04-01 to 2016-06-3013,000USD91
2016-01-01 to 2016-06-3026,298USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-04-01 to 2017-06-308,663USD91
2017-01-01 to 2017-06-30-230USD181
2016-04-01 to 2016-06-30-3,656USD91
2016-01-01 to 2016-06-30-10,778USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-30-22,382USD181
2016-01-01 to 2016-06-30-21,979USD182

Inspect the source

Entity
MATINAS BIOPHARMA HOLDINGS, INC. / CIK 0001582554
Captured
2026-09-20T09:22:54.236Z
SEC response SHA-256
218993fbdcae524fc0c120e888a258d2be15df63a5b4cfc0f198760659dede1e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001582554.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))